Aorfix AAA Stent Graft Body with Aorflex Delivery System SG-HBB-24-81-63-16-A12-22Recalls & reported problems
Lombard Medical Limited · Aorflex AAA Stent Graft Body with Aorflex Delivery System · Class 3 · Implant
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 05055715606813), received between Jun 22, 2016 and Jun 22, 2016 — classified as 1 injury.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
Patient problems
- Aneurysm1
- Occlusion1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryJun 22, 2016Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
THE PROCEDURE WAS PERFORMED BY PLACING A MAIN BODY DEVICE FROM THE RIGHT APPROACH FOLLOWING THE IFU. BECAUSE THE RIGHT COMMON ILIAC ARTERY HAD AN ANEURYSM, THE PHYSICIAN PREOPERATIVELY PLANNED TO PLACE AN EXCLUDER DEVICE (GORE, DIA.: 23 MM) IN THE DISTAL PORTION OF THE IPSILATERAL SIDE. THE PHYSICIAN WENT ON TO DEPLOY A CONTRA-LATERAL LIMB HOWEVER DUE TO A TECHNICAL ERROR, THE OVERLAPPING MARGIN WAS INSUFFICIENT. THE PHYSICIAN ADDED AN EXTENDER (HDE-12-82) AS A BRIDGE TO ADDRESS THIS ISSUE. FOLLOWING REVIEW OF THE DISTAL LANDING ZONE, FURTHER EXTENSION WAS REQUIRED AND THE PHYSICIAN EXTENDED IT WITH A DISTAL EXTENDER DEVICE. ADDITIONALLY, HE ALSO PLACED A BARE STENT TO PREVENT STENOSIS WHILE PERFORMING A LANDING IN THE EXTERNAL ILIAC ARTERY. THE FINAL ANGIOGRAPHY REVEALED A TYPE IV ENDOLEAK AND AN OCCLUSION OF THE RIGHT LOWER RENAL ARTERY. AS A COUNTERMEASURE, THE PHYSICIAN ATTEMPTED TO APPROACH FROM THE BRACHIAL ARTERY, BUT CANNULATION IN THE RENAL ARTERY WAS UNSUCCESSFUL THEREFORE NOT PROGRESSED. THE PHYSICIAN PLACED AN ADDITIONAL BARE STENT IN ORDER TO OBTAIN A GOOD BLOOD FLOW TO THE LEFT RENAL ARTERY. THE PROCEDURE WAS FINISHED.
Patient problems: Aneurysm; Occlusion
MAUDE report 5741606 ↗
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page